Vikas Thapar
Director/Board Member at Kitara PIIN 1102
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeyaretna George | M | - |
Kitara Ofil
 Kitara Ofil Contract DrillingIndustrial Services Kitara Ofil engages in providing oil well logging and analysis. The company is headquartered in Ebene, Mauritius.
Kitara PIIN 1001
 Kitara PIIN 1001 Financial ConglomeratesFinance Kitara PIIN 1001 operates as a pooled investment fund. The company is headquartered in Ebene, Mauritius.
Kitara ASL
 Kitara ASL Financial ConglomeratesFinance Kitara ASL operates as an investment fund. The company is headquartered in Ebene, Mauritius.
Kitara PIIN 1102
 Kitara PIIN 1102 Investment Trusts/Mutual FundsMiscellaneous Kitara PIIN 1102 operates as an investment holding company. The company is headquartered in Ebene, Mauritius. | - |
| Jacques Attali | M | - |
Kitara PIIN 1102
Kitara PIIN 1102 Investment Trusts/Mutual FundsMiscellaneous Kitara PIIN 1102 operates as an investment holding company. The company is headquartered in Ebene, Mauritius.
Kitara Ofil
Kitara Ofil Contract DrillingIndustrial Services Kitara Ofil engages in providing oil well logging and analysis. The company is headquartered in Ebene, Mauritius.
Kitara ASL
Kitara ASL Financial ConglomeratesFinance Kitara ASL operates as an investment fund. The company is headquartered in Ebene, Mauritius.
Kitara PIIN 1001
Kitara PIIN 1001 Financial ConglomeratesFinance Kitara PIIN 1001 operates as a pooled investment fund. The company is headquartered in Ebene, Mauritius. | - |
| Sachin Nithyanand Kamath | M | - |
Kitara PIIN 1001
Kitara PIIN 1001 Financial ConglomeratesFinance Kitara PIIN 1001 operates as a pooled investment fund. The company is headquartered in Ebene, Mauritius.
Kitara ASL
Kitara ASL Financial ConglomeratesFinance Kitara ASL operates as an investment fund. The company is headquartered in Ebene, Mauritius.
Kitara Ofil
Kitara Ofil Contract DrillingIndustrial Services Kitara Ofil engages in providing oil well logging and analysis. The company is headquartered in Ebene, Mauritius.
Kitara PIIN 1102
Kitara PIIN 1102 Investment Trusts/Mutual FundsMiscellaneous Kitara PIIN 1102 operates as an investment holding company. The company is headquartered in Ebene, Mauritius. | - |
| Samit Satish Mehta | M | 44 |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 21 years |
| Umesh Ajitsinh Khimji | M | - |
Kitara ASL
Kitara ASL Financial ConglomeratesFinance Kitara ASL operates as an investment fund. The company is headquartered in Ebene, Mauritius.
Kitara PIIN 1001
Kitara PIIN 1001 Financial ConglomeratesFinance Kitara PIIN 1001 operates as a pooled investment fund. The company is headquartered in Ebene, Mauritius.
Kitara Ofil
Kitara Ofil Contract DrillingIndustrial Services Kitara Ofil engages in providing oil well logging and analysis. The company is headquartered in Ebene, Mauritius.
Kitara PIIN 1102
Kitara PIIN 1102 Investment Trusts/Mutual FundsMiscellaneous Kitara PIIN 1102 operates as an investment holding company. The company is headquartered in Ebene, Mauritius. | - |
| Berjis Minoo Desai | M | 67 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 27 years |
| Satish Ramanlal Mehta | M | 73 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 43 years |
| Namita Vikas Thapar | F | 47 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 18 years |
| Vijay Gokhale | M | 65 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 3 years |
| Vidya Rajiv Yeravdekar | M | 60 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 3 years |
| Palamadai S. Jayakumar | M | 62 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 4 years |
| Mukund Keshao Gurjar | M | 70 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 23 years |
| Sunil Rajanikant Mehta | M | 61 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 41 years |
| Lin-Tsing Yu | M | 80 |
University of California San Diego
| 30 years |
| Farhana Ali Mohamed | M | - |
Kitara Ofil
Kitara Ofil Contract DrillingIndustrial Services Kitara Ofil engages in providing oil well logging and analysis. The company is headquartered in Ebene, Mauritius. | - |
| Deepak Gondaliya | M | - |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 11 years |
| Sanjay Rajanikant Mehta | M | 59 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 35 years |
| Tajuddin Sabir Shaikh | M | - |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 21 years |
| Samonnoi Sajani Banerjee | M | 48 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 6 years |
| Shailesh Ayyangar | M | 69 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 3 years |
| Tony Chou | M | 63 |
University of California San Diego
| 30 years |
| Richard Feinberg | M | 76 |
University of California San Diego
| 28 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Bashyam Renganathan | M | - |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 2 years |
| Girish Laxmikant Telang | M | 74 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
| Bob Whiton | M | - |
University of California San Diego
| 5 years |
| Tony Craddock | M | - |
University of California San Diego
| 8 years |
| Hitesh Jain | M | 50 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
| Fouad Benghalem | M | - |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
| Marvin Samson | M | 82 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | - |
| Dan Mytels | M | - |
University of California San Diego
| 5 years |
| Humayun Raja Dhanrajgir | M | 87 |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | 21 years |
| John Reed | M | 65 |
University of California San Diego
| 20 years |
| Jeffery A. Jones | M | - |
University of California San Diego
| 4 years |
| Anthony Gino Valeri | M | 54 |
University of California San Diego
| 4 years |
| Darren Sherman | M | 52 |
University of California San Diego
| 6 years |
| Jeff Schlosser | M | - |
University of California San Diego
| 4 years |
| David B. Fogel | M | - |
University of California San Diego
| 3 years |
| Daniel Riskin | M | - |
University of California San Diego
| 5 years |
| Greg Little | M | - |
University of California San Diego
| 5 years |
| Joseph Peter Traba | M | - |
University of California San Diego
| 5 years |
| F. Mitchell Thrower | M | - |
University of California San Diego
| 2 years |
| Ryan Heine | M | - |
University of California San Diego
| 4 years |
| Marconi B. Ratonel | M | - |
University of California San Diego
| 4 years |
| Alipour Navid | M | - |
University of California San Diego
| 4 years |
| Ann Crady Weiss | F | - |
University of California San Diego
| 4 years |
| Lisa Alonso | F | 47 |
University of California San Diego
| 4 years |
| Melissa Dominguez | F | - |
University of California San Diego
| 4 years |
| Jonathan Lang | M | - |
University of California San Diego
| 5 years |
| Marcos Rivera | M | - |
University of California San Diego
| 4 years |
| Hanny Jahja | F | - |
University of California San Diego
| 4 years |
| Rebecca Jonah | F | - |
University of California San Diego
| 4 years |
| Khoi D. Dang | M | 50 |
University of California San Diego
| 3 years |
| Edmondo Robinson | M | - |
University of California San Diego
| 4 years |
| Jeff Stone | M | - |
University of California San Diego
| 4 years |
| Thomas Castleberry | M | - |
University of California San Diego
| 4 years |
| Sony Harsono Haribowo | M | - |
University of California San Diego
| 2 years |
| James Hagan | M | 51 |
University of California San Diego
| 4 years |
| Justin Schuster | M | - |
University of California San Diego
| 5 years |
| Hao Shi | M | 61 |
USC Marshall School of Business
| 2 years |
| Taner Halicioglu | M | - |
University of California San Diego
| 4 years |
| Andreas Gottschling | M | 57 |
University of California San Diego
| 3 years |
| Tad Gallistel | M | - |
University of California San Diego
| 4 years |
| Adam Berry | M | 50 |
University of California San Diego
| 4 years |
| Greg Young | M | - |
University of California San Diego
| 4 years |
| Nima Shiva | M | - |
University of California San Diego
| 4 years |
| M. Hinshaw | M | - |
University of California San Diego
| 2 years |
| James D. Samford | M | - |
University of California San Diego
| 4 years |
| David E. DeMers | M | - |
University of California San Diego
| - |
| David Spitz | M | 51 |
University of California San Diego
| 5 years |
| Ray Burnett | M | - |
University of California San Diego
| 4 years |
| Andrew J. Viterbi | M | 88 |
University of California San Diego
| 23 years |
| Thomas Kammeyer | M | - |
University of California San Diego
| 3 years |
| Andy Katz | M | - |
University of California San Diego
| 3 years |
| Joe Gubler | M | - |
University of California San Diego
| 2 years |
| Connie Michelle Paulus | F | 64 |
University of California San Diego
| 7 years |
| Stephanie Tran | F | - |
University of California San Diego
| 4 years |
| Peter Lipson | M | - |
University of California San Diego
| 4 years |
| Eric David Thaller | M | - |
University of California San Diego
| 4 years |
| Joncarlo Mark | M | - |
University of California San Diego
| 5 years |
| Robert G. Anfuso | M | - |
University of California San Diego
| 4 years |
| Ben Block | M | - |
University of California San Diego
| 4 years |
| Travis Rouillard | M | - |
University of California San Diego
| 4 years |
| Richard L. Sowers | M | 51 |
University of California San Diego
| 4 years |
| Chia-Lin Simmons | M | 51 |
University of California San Diego
| 4 years |
| Joseph Hagan | M | 55 |
University of California San Diego
| 4 years |
| John Liu | M | - |
University of California San Diego
| 4 years |
| Michael Ian Waterman | M | - |
University of California San Diego
| 4 years |
| Andy B. Serwin | M | - |
University of California San Diego
| 4 years |
| Joe Riehl | M | - |
University of California San Diego
| 4 years |
| John Engel | M | - |
University of California San Diego
| 4 years |
| Andrew H. Gross | M | - |
University of California San Diego
| 3 years |
| Mark Davis | M | - |
University of California San Diego
| 3 years |
| Daniel McMahon | M | 52 |
University of California San Diego
| 4 years |
| Gregory R. Woodhill | M | - |
University of California San Diego
| 4 years |
| Shah Badkoubei | M | - |
University of California San Diego
| 4 years |
| Chris D. Emery | M | - |
University of California San Diego
| 4 years |
| Richard T. Watling | M | - |
University of California San Diego
| 4 years |
| Eric Richard Bertrand | M | - |
University of California San Diego
| 4 years |
| Riju Khetarpal | M | - |
University of California San Diego
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 74 | 74.75% |
| India | 20 | 20.20% |
| Mauritius | 5 | 5.05% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Vikas Thapar
- Personal Network
